Funding | HIV/Hep C in the Context of Local U.S. Opioid Epidemics (Due 9/12)

Public Policy Awards: Addressing HIV and/or Hepatitis C in the Context of Local U.S. Opioid Epidemics

Funding and Performance Period

Up to $70,000 (including indirect costs at a maximum rate of 20%) for projects to be completed by November 30, 2018.

Deadlines

Registration Deadline: September 12, 2017, 3:00 PM EDT (You must register in order to submit.)
Concept Paper Submission Deadline: September 14, 2017, 3:00 PM EDT

Click here for complete information about the RFP and how to apply.

Purpose and Priority Areas of Interest

This RFP seeks to fund organizations working at the state or local level on efforts to address HIV and/or hepatitis C in the context of the opioid epidemic. Successful applications will incorporate the use of amfAR’s Opioid & Health Indicators Database into proposed projects.

Areas of interest are (in order of priority):

• Identifying and addressing gaps in health care delivery for individuals diagnosed with HIV and/or hepatitis C in the context of a local opioid epidemic
• Identifying and working to amend policies that exacerbate risk for HIV in the context of a local opioid epidemic
• Identifying and address gaps in the availability of harm reduction and other prevention services in areas at high epidemiological risk for an HIV or hepatitis C outbreak
• Increase awareness of amfAR’s Opioid & Health Indicators Database among local health officials, advocates, and policy makers (see description below)

amfAR’s Opioid & Health Indicators Database is a free web platform designed to support communities, lawmakers, and advocates in making informed decisions about the opioid epidemic and its impact on HIV and hepatitis C. The database is a window into the opioid epidemic unfolding in every American’s backyard. It provides local to national statistics using reliable data sources on new HIV and hepatitis C infections, opioid use and overdose death rates, and the availability of services such as drug treatment programs and syringe exchange services. In addition, users can examine data at the state or county level to see the differential impact of the opioid epidemic by state or within states.    

amfAR Opiod & Health Indicators Database

Topics of interest relevant to this RFP include:

• Naloxone availability (e.g., third party prescriptions) and availability to law enforcement and other government employees, as well as affordability
• Syringe services program availability, determination of need process, or legal barriers including paraphernalia laws
• Medication-Assisted Treatment availability (Buprenorphine, Methadone, Naltrexone) and treatment program capacity
• Roadblocks to Medication-Assisted Treatment (e.g., prior authorizations, lifetime limits, patient caps)
• Health insurance coverage for people with opioid use disorder
• Reducing perinatal hepatitis C infection
• Prescriber education about opioid abuse (clinics, private physicians, medical or dentistry schools, etc.)
• Law enforcement education about opioid abuse and people with opioid use disorder

**Project directors must register to receive instructions and portal user name and password for submission of a Concept Paper in response to this RFP.  See the RFP for details.  Log-ins are not transferable. 

Last Updated on February 13, 2018 by HepFree NYC